| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bff8d29c81be4e07ebf0460bf4628c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d3f2c561f6208038c04f32ddcd5fee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a87cfb5631a495c01dfab0b93906dada
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77d3f2a7f0d12954287b4e00a7919ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140d26a164a81e120720b6995bc9d4e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a35ec6382ebc5756a6b7dde7b02b0a |
| publicationDate |
2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-542092-A |
| titleOfInvention |
Use of erythropoietin (EPO) in stroke recovery wherein the EPO is formulated for administration for a particular dosage regime |
| abstract |
Disclosed is the use of EPO in promoting patient recovery following an ischemic event wherein EPO is formulated for administration according to a dosage regime wherein a first dose of EPO is delivered during a period from 8-26 hours after the ischemic event followed by a second dose of EPO delivered within 8-26 after the first dose. |
| priorityDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |